Recombinant Human CLDN11 Protein，His

CLDN11, or Claudin 11, is a critical tight junction protein predominantly expressed in oligodendrocytes, the myelinating cells of the central nervous system. Its primary function involves regulating the paracellular permeability of ions and small molecules, contributing to the maintenance of the blood-brain barrier (BBB) and ensuring proper neuronal function. Research into CLDN11 has gained momentum due to its potential implications in neurological disorders, such as multiple sclerosis and other demyelinating diseases, where the integrity of the BBB is compromised. The study of CLDN11 recombinant proteins aims to elucidate its structural and functional properties, particularly how it forms tight junctions and interacts with other cellular components. By generating and characterizing recombinant CLDN11, researchers can investigate its role in cellular signaling pathways, its potential as a therapeutic target, and its involvement in disease mechanisms. Experimental approaches often include the use of cell cultures, in vivo models, and advanced imaging techniques to assess the physiological impact of CLDN11 modulation. Understanding the biophysical properties and regulation of CLDN11 is essential for developing strategies to enhance CNS repair and mitigate neuroinflammation, thereby paving the way for innovative treatments for related neurological conditions.